The effects of royal jelly for the adverse events of molecular target therapy for renal cancer patients.
Not Applicable
- Conditions
- Renal cell carcinoma
- Registration Number
- JPRN-UMIN000020152
- Lead Sponsor
- Department of Urology and Renal transplantation, Nagasaki University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. those who have possibility of the cancer death within six months 2.those who have allergy for honey 3. those who have some allergy for foods and drugs 4. those who have another cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method